{"id":"W1974540375","doi":"10.1503/cmaj.081713","title":"Thiazolidinediones: Do harms outweigh benefits?","year":2008,"lang":"en","type":"letter","venue":"Canadian Medical Association Journal","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Women's College Hospital","funders":"Canadian Diabetes Association","keywords":"Rosiglitazone; Pioglitazone; Medicine; Glycemic; Diabetes mellitus; Thiazolidinedione; Drug; Intensive care medicine; Drug approval; Type 2 diabetes; Pharmacology; Endocrinology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006305945,0.0007569474,0.001763528,0.0007571634,0.003010308,0.003276808,0.001532739,0.04473657,0.007138137],"category_scores_gemma":[0.04161698,0.0004832476,0.001064618,0.0009711568,0.005304554,0.005726971,0.001264444,0.03680442,0.005705569],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005873502,"about_ca_system_score_gemma":0.003606155,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00495968,"about_ca_topic_score_gemma":0.008951845,"domain_scores_codex":[0.9947811,0.001740916,0.0006697277,0.0005853525,0.001802927,0.0004199479],"domain_scores_gemma":[0.9809102,0.01370025,0.001149671,0.0003087561,0.002781536,0.001149556],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002805052,0.00007130246,0.001764952,0.0002426556,0.00005381069,0.006267047,0.0004316861,0.0001249323,0.000517306,0.01786727,0.9027509,0.06962758],"study_design_scores_gemma":[0.0005802612,0.0002772912,0.002814991,0.001382052,0.0000921329,0.01714933,0.001688477,0.0006359547,0.0004758631,0.06860609,0.9061894,0.0001083163],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0003378147,0.001788426,0.0000827689,0.992976,0.003142581,0.000003425928,0.00001302626,0.000007694472,0.001648414],"genre_scores_gemma":[0.007240965,0.003351089,0.0003279879,0.9609514,0.02564928,0.00001271673,0.00001475881,0.00001069208,0.002441181],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.04473657,"threshold_uncertainty_score":0.04261541,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01184862404293979,"score_gpt":0.2211290017181656,"score_spread":0.2092803776752258,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}